Resilience is a biomanufacturing CDMO focused on improving access to complex medicines, with end-to-end solutions for safe and scalable manufacturing.

Jan 15, 2025 · Resilience Secures Funding to Expand Domestic Manufacturing for Critical Pharmaceutical Ingredients San Diego, CA – October 3, 2024 – National Resilience, Inc., a …

Feb 5, 2024 · Taipei, Taiwan and San Diego, California, February 5, 2024 – National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening …

Launch your pharmaceutical biomanufacturing career with Resilience, where unconventional innovation is the norm and builders and problem solvers rule.

Resilience announced that it has signed a finance agreement for $410 million in long-term loan financing from the U.S. Department of Defense (DoD).

Explore Resilience’s services, including cell line development, viral vector manufacturing, biologics manufacturing, and analytical & process development.

Mar 26, 2025 · Resilience is anticipating that the Cincinnati workforce will grow to nearly 1,000 workers, marking a significant milestone in its rapid growth since Resilience acquired the site …

Resilience announces it has raised $625 million in a Series D financing, in addition to a previously unannounced $600 million Series C financing completed in August 2021.

SAN DIEGO-- (BUSINESS WIRE)-- National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access to complex medicines, today …

Accelerate your biologics and cell line manufacturing projects with Resilience, the biomanufacturing CDMO that’s changing the way medicines are made.